The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
Latest News
Congratulations to Steve O’Rahilly who has today been awarded the prestigious Rank Prize in Nutrition. The Nutrition prize of £80,000…
Fiona Gribble becomes Vice President of EASD
Congratulations to Fiona Gribble who has been nominated as Vice President of the European Association for the Study of Diabetes…
A mechanism for the effects of metformin on body weight and energy balance
New research published in Nature and undertaken in the MRC Metabolic Diseases Unit at the University of Cambridge, with collaborators…
Manpei Suzuki International Prize
Congratulations to Professor Stephen O’Rahilly who has won the 2019 Manpei Suzuki International Prize – a prestigious annual award made…
